186 related articles for article (PubMed ID: 18515259)
1. A general tumour control probability model for non-uniform dose distributions.
González SJ; Carando DG
Math Med Biol; 2008 Jun; 25(2):171-84. PubMed ID: 18515259
[TBL] [Abstract][Full Text] [Related]
2. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
Keall PJ; Webb S
Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
[TBL] [Abstract][Full Text] [Related]
3. Potential implications of the bystander effect on TCP and EUD when considering target volume dose heterogeneity.
Balderson MJ; Kirkby C
Int J Radiat Biol; 2015 Jan; 91(1):54-61. PubMed ID: 25004946
[TBL] [Abstract][Full Text] [Related]
4. A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD).
Luxton G; Keall PJ; King CR
Phys Med Biol; 2008 Jan; 53(1):23-36. PubMed ID: 18182685
[TBL] [Abstract][Full Text] [Related]
5. Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects.
Hoffmann AL; den Hertog D; Siem AY; Kaanders JH; Huizenga H
Phys Med Biol; 2008 Nov; 53(22):6345-62. PubMed ID: 18941280
[TBL] [Abstract][Full Text] [Related]
6. Tumor control and normal tissue complications in BNCT treatment of nodular melanoma: a search for predictive quantities.
González SJ; Casal M; Pereira MD; Santa Cruz GA; Carando DG; Blaumann H; Bonomi M; Calzetta Larrieu O; Feld D; Fernández C; Gossio S; Jiménez Rebagliatti R; Kessler J; Longhino J; Menéndez P; Nievas S; Roth BM; Liberman SJ
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S153-6. PubMed ID: 19386505
[TBL] [Abstract][Full Text] [Related]
7. A heterogeneous dose distribution in simultaneous integrated boost: the role of the clonogenic cell density on the tumor control probability.
Strigari L; D'Andrea M; Abate A; Benassi M
Phys Med Biol; 2008 Oct; 53(19):5257-73. PubMed ID: 18758004
[TBL] [Abstract][Full Text] [Related]
8. A computational dosimetry tool for the study of tumor doses and skin toxicities in BNCT.
Gossio S; Carando DG; González SJ
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S145-8. PubMed ID: 19386508
[TBL] [Abstract][Full Text] [Related]
9. Comparison between the ideal reference dose level and the actual reference dose level from clinical 3D radiotherapy treatment plans.
Bufacchi A; Arcangeli G; delle Canne S; Malatesta T; Capparella R; Fragomeni R; Marmiroli L; Begnozzi L
Radiother Oncol; 2009 Jul; 92(1):68-75. PubMed ID: 19328571
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric parameters in partial breast irradiation through brachytherapy.
Gloi A; McCourt S; Buchanan R; Goetller A; Zuge C; Balzoa P; Cooley G
Med Dosim; 2009; 34(3):207-13. PubMed ID: 19647630
[TBL] [Abstract][Full Text] [Related]
11. Controlling the dose distribution with gEUD-type constraints within the convex radiotherapy optimization framework.
Zinchenko Y; Craig T; Keller H; Terlaky T; Sharpe M
Phys Med Biol; 2008 Jun; 53(12):3231-50. PubMed ID: 18506069
[TBL] [Abstract][Full Text] [Related]
12. Numerical assessment of radiation binary targeted therapy for HER-2 positive breast cancers: advanced calculations and radiation dosimetry.
Sztejnberg Gonçalves-Carralves ML; Jevremovic T
Phys Med Biol; 2007 Jul; 52(14):4245-64. PubMed ID: 17664606
[TBL] [Abstract][Full Text] [Related]
13. BNCT for skin melanoma in extremities: updated Argentine clinical results.
Menéndez PR; Roth BM; Pereira MD; Casal MR; González SJ; Feld DB; Santa Cruz GA; Kessler J; Longhino J; Blaumann H; Jiménez Rebagliati R; Calzetta Larrieu OA; Fernández C; Nievas SI; Liberman SJ
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S50-3. PubMed ID: 19375342
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric comparison between 3DCRT and IMRT using different multileaf collimators in the treatment of brain tumors.
Ding M; Newman F; Chen C; Stuhr K; Gaspar LE
Med Dosim; 2009; 34(1):1-8. PubMed ID: 19181248
[TBL] [Abstract][Full Text] [Related]
15. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships.
El Naqa I; Suneja G; Lindsay PE; Hope AJ; Alaly JR; Vicic M; Bradley JD; Apte A; Deasy JO
Phys Med Biol; 2006 Nov; 51(22):5719-35. PubMed ID: 17068361
[TBL] [Abstract][Full Text] [Related]
16. From cell population models to tumor control probability: including cell cycle effects.
Hillen T; de Vries G; Gong J; Finlay C
Acta Oncol; 2010 Nov; 49(8):1315-23. PubMed ID: 20843174
[TBL] [Abstract][Full Text] [Related]
17. Ideal dose level in treatment planning optimization.
Begnozzi L; Malaspina F; Gentile FP; Chiatti L; Carpino S; Fragomeni R; Benassi M
Strahlenther Onkol; 1992 Oct; 168(10):588-92. PubMed ID: 1440230
[TBL] [Abstract][Full Text] [Related]
18. Reporting and analyzing dose distributions: a concept of equivalent uniform dose.
Niemierko A
Med Phys; 1997 Jan; 24(1):103-10. PubMed ID: 9029544
[TBL] [Abstract][Full Text] [Related]
19. A treatment planning study on glioblastoma with different techniques using boron neutron capture therapy, 3-dimensional conformal radiotherapy, and intensity modulated radiotherapy.
Jung SH; Yoon SM; Park SH; Choi IS; Kim JK; Choi EK; Ahn SD; Lee SW; Song SY; Kim JH
Appl Radiat Isot; 2009; 67(7-8):1180-4. PubMed ID: 19321353
[TBL] [Abstract][Full Text] [Related]
20. Cell-cycle times and the tumour control probability.
Maler A; Lutscher F
Math Med Biol; 2010 Dec; 27(4):313-42. PubMed ID: 19966342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
